Figure 4.Analysis of association between LPCATs Score and immune infiltrating, potent anticancer inhibitors. (A) The link between LPCATs Score and immune infiltrating score in pan-cancer was illustrated. (B) The value of LPCATs Score in predicating response outcomes and OS in immune checkpoint blockade (ICB) sub-cohorts was demonstrated. (C) The link between gene expression and the sensitivity of GDSC pharmaceuticals (top 30) was represented. (D) The top 30 CTRP pharmaceuticals and their sensitivity to pan-cancer expression profiles are presented.
